Novel genetic risk factors influence progression of islet autoimmunity to type 1 diabetes
Journal Article
·
· Scientific Reports
- Univ. of Virginia, Charlottesville, VA (United States)
- Univ. of Colorado Anschutz Medical Campus, Aurora, CO (United States)
- Pacific Northwest National Lab. (PNNL), Richland, WA (United States); Univ. of Colorado Anschutz Medical Campus, Aurora, CO (United States)
Type 1 diabetes arises from the autoimmune destruction of insulin-producing beta-cells of the pancreas, resulting in dependence on exogenously administered insulin to maintain glucose homeostasis. In this study, our aim was to identify genetic risk factors that contribute to progression from islet autoimmunity to clinical type 1 diabetes. We analyzed 6.8 million variants derived from whole genome sequencing of 160 islet autoantibody positive subjects, including 87 who had progressed to type 1 diabetes. The Cox proportional-hazard model for survival analysis was used to identify genetic variants associated with progression. We identified one novel region, 20p12.1 (TASP1; genome-wide P < 5 × 10–8) and three regions, 1q21.3 (MRPS21–PRPF3), 2p25.2 (NRIR), 3q22.1 (COL6A6), with suggestive evidence of association (P < 8.5 × 10–8) with progression from islet autoimmunity to type 1 diabetes. Once islet autoimmunity is initiated, functional mapping identified two critical pathways, response to viral infections and interferon signaling, as contributing to disease progression. These results provide evidence that genetic pathways involved in progression from islet autoimmunity differ from those pathways identified once disease has been established. These results support the need for further investigation of genetic risk factors that modulate initiation and progression of subclinical disease to inform efforts in development of novel strategies for prediction and intervention of type 1 diabetes.
- Research Organization:
- Pacific Northwest National Laboratory (PNNL), Richland, WA (United States)
- Sponsoring Organization:
- Leona M. and Harry B. Helmsley Charitable Trust; National Institutes of Health (NIH); USDOE
- Grant/Contract Number:
- AC05-76RL01830
- OSTI ID:
- 1713200
- Report Number(s):
- PNNL-SA--151476
- Journal Information:
- Scientific Reports, Journal Name: Scientific Reports Journal Issue: 1 Vol. 10; ISSN 2045-2322
- Publisher:
- Nature Publishing GroupCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Decrease in multiple complement proteins associated with development of islet autoimmunity and type 1 diabetes
Increased inflammation as well as decreased endoplasmic reticulum stress and translation differentiate pancreatic islets from donors with pre-symptomatic stage 1 type 1 diabetes and non-diabetic donors
Prediction of the development of islet autoantibodies through integration of environmental, genetic, and metabolic markers
Journal Article
·
Tue Dec 19 19:00:00 EST 2023
· iScience
·
OSTI ID:2375811
Increased inflammation as well as decreased endoplasmic reticulum stress and translation differentiate pancreatic islets from donors with pre-symptomatic stage 1 type 1 diabetes and non-diabetic donors
Journal Article
·
Sun Jun 01 20:00:00 EDT 2025
· Diabetologia
·
OSTI ID:2570268
Prediction of the development of islet autoantibodies through integration of environmental, genetic, and metabolic markers
Journal Article
·
Tue Jul 21 20:00:00 EDT 2020
· Journal of Diabetes (Online)
·
OSTI ID:1756070